Microorganisms 9(5):1034 Miller BC, Mathai M, Yadav H, Jain S (2024) Geroprotective potential of microbiome modulators in the Caenorhabditis elegans model
GLP-1s, drugs like Ozempic and Wegovy, cost Connecticut more than $80 million last year
It is an exceedingly rare disease, afflicting one out of 35,000 individuals perhaps 10,000 people in the US
Semaglutide (Wegovy, Ozempic, Rybelsus) is an FDA-approved medicine used for chronic weight management in individuals who are overweight or with general obesity with at least one weight-related disorder (such as type 2 diabetes, high cholesterol, or high blood pressure) in addition to increased physical activity or a reduced calorie diet
Human dosing figures circulating in the research community are either human-equivalent-dose extrapolations from mouse protocols or vendor-driven tablet/capsule suggestions with no primary-source backing
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
